Ugonin P inhibits lung cancer motility by suppressing DPP-4 expression via promoting the synthesis of miR-130b-5p

This study provides compelling evidence that ugonin P could be used to develop novel therapeutic agents for the treatment of lung cancer.PMID:37703658 | DOI:10.1016/j.biopha.2023.115483

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - September 13, 2023 Category: Drugs & Pharmacology Authors: Chih-Ying Wu Shubham Suresh Ghule Chih-Chuang Liaw David Achudhan Shuen-Yih Fang Po-I Liu Chang-Lun Huang Ching-Liang Hsieh Chih-Hsin Tang Source Type: research